TRENTON, N.J. – Merck & Co. (MRK), under siege because of lost revenues from its recalled blockbuster arthritis drug Vioxx, will cut about 5,100 jobs by year's end, more than originally planned, and ...

Drugmaker Merck & Co.'s (NYSE: MRK) second-quarter profit nearly tripled from a year ago, when about $2 billion in charges hurt results. Merck also said Friday that it will cut up to 11,830 jobs. The ...

Merck broke ground on a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Del., the Rahway-based company announced April 29. The Merck Wilmington Biotech ...

Add Yahoo as a preferred source to see more of our stories on Google. The logo of the pharmaceutical and chemical company Merck is displayed on flags on a building at its headquarters in Darmstadt.

Merck & Co. plans to cut as many as 13,000 more jobs under a new round of restructuring as the drugmaker prepares for generic competition for its top-selling drug and slower revenue growth in the U.S.